EctoPharma
  • Home
  • ABOUT US
    • The Company – What we do
    • Business Model
    • Current Work
    • Who’s Who
    • In the Media
      • December 2010
      • September 2010
      • June 2010
      • December 2009
  • OUR PRODUCTS
    • KindaPed™
      • UK Launch of “Hedrin Treat & Go”
      • Properties of KindaPed™
      • Current Lice Treatments
      • Efficacy
      • Market Size
  • SHAREHOLDERS
    • Presentations
    • Letters
  • Contact us

Market Size:

Head lice infestations occur across all socio-economic and age groups.  The annual global market for licensed over-the-counter head lice products is significant with some estimates putting the total at around £200 million.  In the USA alone, it is estimated (source: Destum Partners Inc) that more that $100 million is spent annually to combat head lice.   6 to 12 million infestations occur each year among US children between 3 and 11 years of age.

These estimates do not include the sales of non-licensed products such as tee tree oil, neem oil and other “natural” remedies.

Nor do they include potential applications for the product in the animal health market.   EctoPharma believes KindaPed™ could play a significant role in tackling the problems of various insect and mite infestations in both domestic animals (mainly cats & dogs) and agricultural livestock and is actively pursuing investigations in this area.

 

 

Comments are closed.



KindaPed™

  • UK Launch of “Hedrin Treat & Go”
  • Properties of KindaPed™
  • Current Lice Treatments
  • Efficacy
  • Market Size
Go To Top »

Copyright Ectopharma 2011